← Browse by Condition
Medical Condition
inflammatory bowel diseases
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2, Phase 3, Phase 2
NCT06042387
Recruiting
Genome Analysis Across Populations in Inflammatory Bowel Disease
Enrollment
150 pts
Location
Canada
Sponsor
Mount Sinai Hospital, Canada
NCT03894228
Recruiting
Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)
Enrollment
1,750 pts
Location
Spain
Sponsor
Grupo Espanol de Trabajo en En...
NCT04280510
Recruiting
Pathogenic Study of Adult Immune Enteropathies
Enrollment
200 pts
Location
France
Sponsor
Institut National de la Santé ...
NCT06512441
Recruiting
Vitamin B6 Aids in Treating Inflammatory Bowel Disease
Enrollment
220 pts
Location
China
Sponsor
Changhai Hospital
NCT06447870
Recruiting
Research on the Mechanisms of Treatment Non-response in Inflammatory Bowel Disease Based on Multi-omics Technology
Enrollment
30 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
NCT06550310
Recruiting
Nutrition and Clinical Outcomes in IBD
Enrollment
300 pts
Location
United Kingdom
Sponsor
Barts & The London NHS Trust
NCT06382519
Recruiting
Thalidomide Therapy for VEOIBD
Enrollment
40 pts
Location
China
Sponsor
Children's Hospital of Fudan U...
NCT04995224
Recruiting
Mechanism of Chronic Pain in Patients With IBD
Enrollment
25,600 pts
Location
United Kingdom
Sponsor
Queen Mary University of Londo...
NCT06309017
Recruiting
Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
Enrollment
150 pts
Location
United States
Sponsor
NYU Langone Health
NCT05986136 Phase 2, Phase 3
Recruiting
Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Enrollment
50 pts
Location
Egypt
Sponsor
Mostafa Bahaa
NCT06453317 Phase 2
Recruiting
Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
Enrollment
172 pts
Location
Poland
Sponsor
Medical University of Lodz